Kamakura, Japan

Aiko Takayama


 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Kanagawa, JP (2016)
  • Kamakura, JP (2015 - 2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Aiko Takayama: Innovator in Cancer Treatment

Introduction

Aiko Takayama is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of cancer treatment through his innovative pharmaceutical compositions. With a total of 7 patents, Takayama's work focuses on developing methods and compositions that aim to improve cancer detection and treatment.

Latest Patents

One of Takayama's latest patents is a pharmaceutical composition for treating and/or preventing cancer. This invention provides a novel composition that includes a polynucleotide derived from various miRNAs associated with cancer. It also features a combination drug that includes another antitumor agent, along with a method for treating or preventing cancer in affected subjects. Another significant patent involves a method and kit for detecting biliary tract cancer. This invention measures the amounts of APOA2 protein variants in a test sample using anti-APOA2 antibodies, which are also included in the detection kit for biliary tract cancer.

Career Highlights

Throughout his career, Aiko Takayama has worked with notable organizations such as Toray Industries, Inc. and the National Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research and treatment.

Collaborations

Some of Takayama's notable coworkers include Atsuko Miyano and Hiroko Sudo, who have contributed to his research endeavors.

Conclusion

Aiko Takayama's innovative work in cancer treatment and detection showcases his dedication to improving healthcare outcomes. His patents reflect a commitment to advancing medical science and providing new solutions for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…